Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma Pharmaceuticals

13/04/2026 15:29

RNS Number : 2565A

Hikma Pharmaceuticals Plc

13 April 2026

 

 

Hikma Pharmaceuticals PLC - EIP Vesting

 

LONDON, 13 April 2026: Hikma Pharmaceuticals PLC (LSE: HIK) (Nasdaq Dubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMRs") have received shares as a result of the vesting of their conditional share awards which were granted on 9 April 2024 under the 2023 Long-Term Incentive Plan ("LTIP").

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Julie Hill

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Julie Hill
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each ("Shares")
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from the vesting of conditional awards under the LTIP.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
Nil
8,188
d)
Aggregated information
Price(s): nil
Volume(s): 8,188
e)
Date of the transaction
9 April 2026
f)
Place of the transaction
London Stock Exchange (XLON)
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each ("Shares")
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares sold to cover tax following the vesting of conditional awards under the LTIP.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£13.09
3,121
d)
Aggregated information
Price(s):£13.09
Volume(s): 3,121
Total(s): £40,851.53
e)
Date of the transaction
9 April 2026
f)
Place of the transaction
London Stock Exchange (XLON)

 

Sam Park

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Sam Park
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each ("Shares")
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from the vesting of conditional awards under the LTIP.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
Nil
19,045
d)
Aggregated information
Price(s): nil
Volume(s): 19,045
e)
Date of the transaction
9 April 2026
f)
Place of the transaction
London Stock Exchange (XLON)
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each ("Shares")
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares sold to cover tax following the vesting of conditional awards under the LTIP.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£13.09
7,259
d)
Aggregated information
Price(s): £13.09
Volume(s): 7,259
Total(s): £95,014.82
e)
Date of the transaction
9 April 2026
f)
Place of the transaction
London Stock Exchange (XLON)

 

 

 

Helen Middlemist

Group Company Secretary

+44 (0)20 7399 2760

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBSGDSIDBDGLX